Skip to main content

Before you Buy: Check the Credit Tab to Make Sure Your Jurisdiction is Accredited!

Back to Search

Not Found
On Demand

International Emerging Markets - Regulation at the Jurisdictional Level


Average Rating:
Not yet rated
Category:
Emerging Markets |  International Law |  International Webinar
Faculty:
Jason Moscovici |  Marie Sanchez |  Dr. Jayashree Mitra |  Daniel Haymann, MBA
Duration:
1 Hour 06 Minutes
Format:
Audio and Video
SKU:
INCBA090522intlregOD
License:
Access for 6 month(s) after purchase.



Description

“What” a global cannabis industry will look like has been subject to as much speculation as the question of “when”. The famous “3 to 5 year” predictor has become the standard answer to any question touching the timing of a new international market. While jurisdictions such as Canada have given us a glimpse into some of the legal issues faced by a country choosing to legalize federally, other models have since emerged. What are these new jurisdictions? What do they have in common? What legal issues are they facing? Join us for a showcase of other countries who have recently “emerged” to join the global adult use, therapeutic, and industrial hemp markets.

Credits


General

This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules. 

INCBA webinars are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.

INCBA on demand programs are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted.

For current accreditation status, please select your jurisdiction below.



Handouts

Faculty

Jason Moscovici's Profile

Jason Moscovici Related seminars and products

Partner, Lawyer, Biochemist

Robic, LLP


Jason Moscovici is a partner, lawyer and biochemist with ROBIC, LLP, a multidisciplinary intellectual property law firm from Quebec, Canada. His IP practice specializes in regulated industries such as food, alcohol, cannabis, pharmaceuticals, medical devices, cosmetics, natural health products, advertising and consumer products.

 

Jason’s focus on the valorization and enforcement of intellectual property, as well as the numerous compliance issues that orbit regulated industries, have allowed him to quickly become one of the most trusted legal advisors to the emerging cannabis industry. His perspectives on compliance, intellectual property and the commercial hurdles related specifically to cannabis are routinely solicited by stakeholders in this space.

 

Jason leads ROBIC`s cannabis group and sits on the life sciences committee of the firm.


Marie Sanchez's Profile

Marie Sanchez Related seminars and products

Partner

Delcade Avocats & Solicitors


Marie has been a partner at DELCADE since 2022 and is a member of the Healthcare & Life Sciences team. Her activity is mainly focused on regulatory aspects related to Life Sciences.

Marie advises and represents the interests of various players in the Life Sciences sector (pharmaceutical companies, medical devices, nutraceuticals, cosmetics, food supplements, biocides, veterinary drugs, etc.) at all stages of the lifecycle of their products and services. She has also developed an in-depth expertise on regulatory and legal issues related to the emerging therapeutic cannabis and wellness hemp/CBD industries.

Her expertise spans advisory work on regulatory issues (general product regulation, clinical research, market access, product advertising, compliance, industry/healthcare professionals’ relations (anti-gift and transparency rules), vigilance, etc.) and on contractual matters. She also represents her clients in litigation before civil, commercial and administrative courts and assists them in their dealings with competent authorities (ANSM, CEPS, ANSES, ANMV, DGCCRF…). Her clients include companies of all sizes: large groups, SMEs and start-ups, both French and international.

A member of the Paris and Quebec Bars, Marie holds a Master II in Healthcare Industry Law from the University of Montpellier I, as well as an Executive MBA from ESSEC-Mannheim. After starting her career in Singapore with a major pharmaceutical group, she practiced for nearly 10 years in renowned international law firms before founding her own practice in 2020. She is a frequent speaker at international seminars and conferences on regulatory issues, particularly in relation to the cannabis industry. Outside the firm, Marie is a member of the International Cannabis Bar Association (INCBA) and the French Regulatory Affairs Association (AFAR).

Her motto:

“They did not know it was imposible, so they did it”  (Mark Twain)


Dr. Jayashree Mitra's Profile

Dr. Jayashree Mitra Related seminars and products

Partner

Fox Rothschild LLP


Jayashree is an accomplished intellectual property attorney with detailed knowledge of the pharmaceutical, biotech, legal cannabis, psychedelics and emerging technology sectors.

She represents clients in federal court and before the Patent Trial and Appeal Board (PTAB) and International Trade Commission in a full range of patent litigation, including Hatch-Waxman actions, Inter Partes Review (IPR) and Post Grant Review (PGR) proceedings and trade secrets disputes. She also has experience handling antitrust matters, as well as intellectual property due diligence and technology agreements for mergers, acquisitions and other corporate transactions.

A former neuropharmaceutical researcher at Yale University, Jayashree's technical knowledge extends to small molecules, protein therapeutics, protein conjugates, vaccines, injectables, biologics and biosimilars, as well as blockchain and data privacy. She is recognized as a Certified Information Privacy Professional/U.S. Private Sector (CIPP-US) by the International Association of Privacy Professionals.


Daniel Haymann, MBA's Profile

Daniel Haymann, MBA Related seminars and products

Senior Associate

MLL Meyerlustenberger Lachenal Froriep Ltd


Daniel Haymann’s practice focuses on international and domestic commercial litigation and arbitration as well as corporate and commercial law.

He established the first dedicated cannabis desk at a large law firm in Switzerland and advises investors, start-ups and vertically integrated companies in the cannabis industry along the value chain, including, among others, on regulatory matters (advice includes all regulatory aspects relating to THC, CBD and other cannabinoids; cultivation and distribution, including GMP and GDP standards, as well as retail; EU Novel Food; cosmetics law; medicinal cannabis products under the supervisory authority Swissmedic (as well as Herbal Medicines)).

He gained extensive experience as a commodity trader and in managerial positions in the coal, petroleum coke and fertiliser industries for the two leading international commodity trading firms in their respective fields. He was based in Zurich, Baar, Singapore and Hong Kong. He then joined an International Finance and Business Development Boutique as partner and held management positions in corporate business development.


Reviews

Please wait ...

Back to Top